Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GT-02287 in Parkinson's Disease
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GT-02287 in Parkinson's Disease
Recruiting · NCT06732180 · Registry updated 2025-05-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GT-02287 in Parkinson's Disease | Parkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy | Recruiting | Phase 1 | 2025-05-06 | NCT06732180 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Gain Therapeutics, Inc. | 2 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Alfred Health | Melbourne | Australia | 3 |
| CMAX | Adelaide | Australia | 2 |
| Princess Alexandra Hospital | Woolloongabba | Australia | 10 |
| Royal Melbourne Hospital | Parkville | Australia | 4 |
| Southern Neurology | Kogarah | Australia | 1 |
| St Vincent's Hospital Sydney | Darlinghurst | Australia | 2 |
| Westmead Hospital | Westmead | Australia | 4 |